Diabetic retinopathy (DR) is a leading cause of blindness, particularly among diabetic patients. Early detection is crucial for preventing vision loss, but access to regular eye screenings can be a challenge. This is where Artificial Intelligence (AI) steps in, offering a promising solution for the early detection and improved management of DR.

The Power of AI in Eye Care

In healthcare, artificial intelligence (AI) is making significant strides, particularly in the field of ophthalmology. One area where AI is revolutionizing the landscape is by empowering ophthalmologists with smart, teleretinal screenings, a process that uses remote technology to examine the retina for signs of eye disease.